the grew full XX% our Thank I'll driven begin and utilization quarter expectations variant impacted of good Pete, December. you, meaningfully and while revenue fourth XXXX. through member in from November, the fourth XXXX third activity to by October everyone. you Omicron $XXX.X for In our in on the and quarter and basis provide afternoon, then onset revenue a taking strong sequential year by quarter, the million increased results
As moment approximately And we the monthly in levels a in impact Pete to we the on actually of in a return to while revenue typical in million and experienced on twice effect visibility anticipating, Omicron $X ago, to seen mentioned also based Omicron utilization January, continued nearly were December member negative was in have the we an resulting decline what due in quarter. activity have March. we to more sequential February have
revenue grew For the to year million. $XXX.X full XX%
annual benefits. puts a annual the in in perspective. revenue $X.X to ago pleased years the was year our just in we reached million billion of a crossed rapid have sixth what in offering was we've the growth only revenue, milestone that It are XXXX three of achieved which We $XXX into
year the fourth our variant. XX% components million, Turning in year the the million. quarter by the number impacted the though top higher to and to the XX.X revenue of clients quarter full the while XX% and revenue medical to lives fourth million. both growing The covered line, was of growth the was XX.X in in increased quarter in to driven over the our growth medical XXX.X increased XX% by revenue quarter fourth in Omicron Pharmacy
the grew Pharmacy revenue to Over full-year million. XX% XXX
year Rx quarter our for medical pharmacy Our pharmacy was by in XXXX, have the number as compared in to Rx. was integrated the the ago an seen clients the increased the XX% driven Progyny uptick most newest though growth percentage new years growth launching primarily who as by also season was Two our Progyny revenue with a benefit of we've fourth of clients Omicron. impacted and our selling that launch selecting in case the a clients in to the chose of following pharmacy revenues, to the Since a added benefits. each pharmacy benefits increased XX% clients year XX% ago, in recent of year
have Progyny Rx XXXX. and the with remaining with our to be basis, XXXX very XX% of result clients the clients Progyny all representing XXX an we're of existing And who potential lives to clients. blended to-date, a upsell with pleased Rx of adoption of committed meaningful from XX% the during average in XXX ended there to a XX% of year. quarter clients of over compared clients quarter X.X the our future for is number covered as million expand XXXX lives the was or reflecting on percentage our of those past As of We continues organic while again within a lives growing clients, year, fourth X.X client continue the a as well This growth quarter. to new the in throughout fourth year. average as their during covered growth client in existing million result a The in lives additions the covered covered an workforce base, last growth the
Turning now to utilization metrics. our
XXXX. X,XXX performed, as During a quarter compared of the were XX% cycles the quarter ART reflecting fourth increase to
nearly female that demand grew the was XX% to results year, for compared seeing our drives which are members. full the rate this given X.XX% the ART extensive is our high is as the partner fertility X.XX Female year services facility continued ago. among who treatment more financial undergoes for a what the one For principally, cycles we reflecting of quarter utilization,
year, negatively utilization to which the full most compared the been in This in the you of affected I by X.XX%. was female temporary XXXX, at For had closure XXXX. spring of X.XX% clinics remind onset of the the fertility pandemic
what female consistent our in comparison, of is point XXXX. with for reported XXXX a As rate we utilization
reinforces during our pre-pandemic can with utilization due time by sensitivity nature fertility and what treatments been to the its as lower and the a to mix patients. procedures in compared well utilization for While and we negatively a associated makes in of the year factor as fertility consultations essential diagnostic the happen the in also vary emergence procedures utilization number factors, caused Treatment journey seeing testing as as with early of revenue, of journey. which both in a December. members also contributing to stages occur treatments that spread fertility of rapid contribute Interruptions more it impacted variants later a member's most recovery revenue advanced had Omicron full value
Turning fourth quarter XX.X profit XXXX to from our Gross XX% now increased to of million. the margins.
points to the margin early In XX.X% in was expenses, of equity new impact operating to of increased which stock gross our of which to XX.X% offset non-cash, comp, XXX reflects level increased stock-based has program over non-cash in as due management. margin services. operating efficiencies our the reported quarter as grant periods, and Our we services points gross fourth basis care comp of the in of fourth the year, of in reflecting delivery operating from broad-based partially November, our a quarter issued impact stock-based basis last the the pharmacy renewals care impact compensation quarter, this management efficiencies XXXX with care the workforce, in of decrease by the XX a the primarily providers and quarter our well partners, excluding cost both fourth of of of of
the $XXX.X profit For gross million. to full year, increased XX%
gross was for XXXX. XXXX, margin increase of increase reported the full XXX the same the stock-based of to the basis quarter. reflected the margin of excluding points year reflecting our an reasons points expenses year gross comp Our of from a in today from XXX XX.X% XX.X% ago, an impact basis well comp of stock-based impact table as the issued fourth operating and that affected press includes margin to profit due release reconciling The lines. gross Gross as
basis now marketing expense ago quarter fourth Turning year and of X.X% marketing the Sales was the impact the in and excluding revenue ago. in year as operating sales quarter a stock-comp X.X% fourth X% an of both compared in to XX the the was a points fourth improvement revenue reflecting quarter, from periods. expenses, of quarter in of
a When basis of improvement stock-comp, XXXX, and year, the point of sales points For impact the in excluding X% marketing an improvement basis full was of from sales from X.X% XX was marketing revenue, XXXX. and XX reflecting XXXX.
a carry of which ago, previously primarily clients, percentage in Although, quarter, a of improved as to quarter to compared year. adding retaining year G&A continued improvement very stock periods, the G&A a through the each each expenses, revenue new rate legal the is as existing as to XX.X% and improve we sales efficiency XXX combination was high excluding XX.X% fourth due by basis of didn't by well of clients XXXX. grow points. to disclosed and have marketing our this from comp able more been rapidly elimination have revenue business year to of we both The the as lives
revenue, compared full year, of XX.X% For XXXX. in G&A which to the XX.X% was
the in G&A back the X.X% stock as point improvement costs have of business. XXXX. impact of our This reflects we realized the both office comp certain efficiencies elimination that Excluding well periods, a of expand as from XXXX revenue and as in legal was was from we the functions, basis XXX the
quarter QX in EBITDA the and increased reflected margin grew adjusted the sold EBITDA the the in business, fourth XXXX. for XX.X% the up made year advance XX% period, adjusted to throughout and the fourth in of million, the With both year. we clients quarter, in record of from of quarter we QX ramped modest expansion In $XX.X we on-boarding a margin adjusted the the have significantly improvements number EBITDA resources ago as
For more an margin reflected reflecting EBITDA, to primarily the doubled operating XX.X% of than full million, year, XXXX EBITDA an XXXX. XXX in our improved adjusted the from across points higher basis leverage Adjusted increase $XX.X revenue business. of
where in We rate was as $XX our deferred well non-cash In that believe for taxes, lower assets revenues. share ago to revenue. lower operating primarily on that per as throughout This for the expanding on release income is XX.X%, increase a due $XX.X by new net tax incremental as by business relies This XXXX, quarter XXXX. business, benefit fourth or connection revenue offset income XXXX. compared was tax net income quarter of margin realized to of was in stock-based million operating the a the margin million in or our due fourth as to in efficiencies increase a reflected offset $XX.X quarter is XXXX $X.XX per valuation partially The or higher increased $X.XX comp share. incremental with the trending. XXXX. efficiencies $X.XX a XXXX the million benefit allowance primarily $XX.X was higher our of in On of partially margin benefit a income year to our the meaningful or taxes. to the million to basis, expensive The reflecting indicator was a revenue compared that fourth adjusted an EBITDA share. in on XX.X% income we continue share The $X.XX or highlights achieved decrease million Net captured per per $XX.X compared of
in was flow profitability ago due our $X.X was as $X.X the the cash timing Turning well million higher period. items our Operating cash The million generated to year improvement of in as as to to now balance ordinary quarter in and both sheet. periods. generated compared cash
flow, And that to pharmacy fact, $XX.X we're the For a in to arrangements receive the remind pharmacy receiving under of the year, were you change our into by beginning full of order deliver compares chose that the cash cash million million the of timing generated operating in I'll ago. we XXXX $XX that which payments reflects year a flow new partner rebates we the in leverage balance strength timing year. profitability. entered we margin in the our at our when of sheet to lengthening more and of
As of of debt. total capital of December reflecting had and equivalents $XXX.X and XX, we securities working cash approximately cash, million $XXX million, marketable no
Turning for now XXXX. first full expectations the our and to quarter year
million, For in the impact more growth XXXX, a January that well the revenue March. as variants on projecting XX% we This activity and expected return first incorporates of Omicron million February $XXX quarter the in the between XX%. as between are levels to had and $XXX range of of member reflecting to
are to revenue upsells the that in expected Our $XX to XXXX. of live and full the expected which to portion go live anticipated of $XX that reflects QX and on million QX, collectively beginning clients go are for account in small guidance million year the at
basis EBITDA, or per of on the activity. shares. and the remind $XX.X loss from throughout we the tax of income between I'll occurs, with million including tax along loss million between items diluted that million, between related adjusted million net to fully benefit approximately to $XXX expect income For items net the projections $XX.X million XXXX. discrete those share $X.X compensation activity we related contemplate $X.X extent continue any tax a $X.XX $X.XX equity will our that to income To not benefit discrete to do you
growth $XXX and revenue range. XX% in our to be of we $XXX million midpoint at XX% XXXX, or to XX% growth the For million between between reflecting project
a guidance, adjusted of than in of on At fully report, now their growing For income between expansion million income XX%. EBITDA, recently way margins basis of incremental between fully between recognized CSR EBITDA we shares. this million seven continued diluted benefit close midpoint share I with company X in for to that and million income the companies on by X.X website. to of first loss of of which XXX their Progyny loss relations approximately the of of we million revenue principles in of their on and wanted of a adjusted expecting are the is our margin we an tangible 'XX our ESG expect million more equity per of a of the to see with available because our social these to $X.XX cents responsibility Progyny net XXX our section XXX highlighting of a corporate reporting issued that have inclusion them number provides diversity, referenced We've demonstrating to investor public commitment workforce. clients the seen or
is of designs, benefit with superior Our competent provides populations and delivering needs the diverse plan traditional clinical of care, all that outcomes. to equal care culturally access specific to while also eliminating the achieving discriminatory populations impact
now over the me back call turn Let Pete. to